Related Experiment Videos
Deletion in blood mitochondrial DNA in Kearns-Sayre syndrome
N Fischel-Ghodsian1, M C Bohlman, T R Prezant
1Ahmanson Department of Pediatrics, Cedars-Sinai Medical Center, Los Angeles, California 90048.
Abstract:
Mitochondrial DNA deletions have been described in the Kearns-Sayre syndrome (KSS) and the Pearson's marrow-pancreas syndrome. In some cases, the same 4,977-bp deletion has been identified in these two very different diseases. Therefore, it is not currently possible to predict the clinical phenotype from the size or location of the deletion. Instead, differential tissue distribution of the deletion has been implicated as one possible determinant of phenotype. In particular, in KSS the deletions have not been detected by Southern blotting in the blood, whereas in Pearson's syndrome they are easily detectable. We describe here an 11-y-old boy with clinically characteristic KSS and a 7.4-kb mitochondrial DNA deletion between nucleotides 7,194 and 14,595. Southern blotting reveals that 75% of the mitochondrial DNA molecules from his peripheral blood have this deletion. This case blurs further the molecular distinction between the KSS and Pearson's marrow-pancreas syndrome, questioning whether tissue distribution is a sufficient explanation for the very different phenotypes of these disorders.
Insights
Mitochondrial DNA deletions are linked to Kearns-Sayre syndrome (KSS) and Pearson syndrome. A case study reveals a large deletion in KSS peripheral blood, challenging current phenotype explanations.
Area of Science:
- Genetics
- Molecular Biology
- Clinical Medicine
Background:
- Mitochondrial DNA (mtDNA) deletions are implicated in Kearns-Sayre syndrome (KSS) and Pearson's marrow-pancreas syndrome.
- A common 4,977-bp deletion is found in both diseases, making phenotype prediction difficult based solely on deletion characteristics.
- Differential tissue distribution of mtDNA deletions is hypothesized to influence disease phenotype.
Observation:
- A patient with KSS presented with a 7.4-kb mtDNA deletion.
- Southern blotting detected this deletion in 75% of peripheral blood mitochondrial DNA molecules.
- This high prevalence in blood contrasts with typical KSS findings where deletions are often undetectable in blood.
Findings:
- The identified 7.4-kb deletion spans nucleotides 7,194 to 14,595.
- The significant presence of this deletion in peripheral blood of a KSS patient challenges the established molecular distinctions between KSS and Pearson syndrome.
- This finding suggests that tissue distribution alone may not fully explain the divergent clinical presentations.
Implications:
- The molecular basis for phenotypical differences between KSS and Pearson syndrome requires further investigation.
- Rethinking the role of mtDNA deletion tissue distribution in determining disease phenotype is necessary.
- This case highlights the complexity of genotype-phenotype correlations in mitochondrial disorders.